brilla
thin
flexibl
heteropolymer
proteinac
appendag
expos
capsulelik
materi
around
cell
surfac
certain
escherichia
coli
strain
two
antigen
peptid
spike
glycoprotein
tgev
amino
acid
aa
transmiss
gastroenter
viru
tgev
tandemli
introduc
loopstructur
variabl
region
aa
major
clpg
subunit
protein
compos
bulk
result
hybrid
jibrilla
aa
heterolog
peptid
produc
cell
surfac
use
monoclon
antibodi
mab
specif
tgev
epitop
purtji
hybrid
jibrilla
analys
western
blot
nativ
condit
show
two
viral
epitop
recogn
immunolog
integr
part
hybridfibrilla
therefor
antigen
activ
immunogen
fusion
construct
evalu
live
recombin
bacteria
purtji
hybrid
clpg
monom
purifi
chimer
polym
whatev
form
hybrid
use
antigen
intraperiton
immun
outbr
mice
elicit
serum
antitgev
peptid
antibodi
ab
sign
cant
titr
capabl
recogn
nativ
tgev
particl
indic
epitop
expos
immunogen
conform
case
howev
viru
neutral
titr
obtain
immun
either
pur
ed
polym
monom
furthermor
month
ultim
immun
ug
hybrid
jibrilla
mice
develop
strong
anamnest
ab
respons
two
tgev
peptid
follow
booster
inocul
virion
conclud
jibrilla
carri
combin
tgev
epitop
insert
induc
immunolog
memori
outbr
anim
infect
tgev
therefor
hybrid
fibrilla
may
prove
efici
compon
subunit
vaccin
copyright
elsevi
scienc
ltd
novemb
revis
june
accept
juli
fibrillum
plasmidencod
heteropolymer
protein
previous
identifi
among
anim
human
enterotoxigen
septicem
escherichia
coli
strain
comparison
amino
acid
aa
sequenc
major
subunit
protein
fibrilla
name
reveal
variabl
region
clpg
aa
form
flexibl
loo
structur
assess
topolog
model
clpg
b
region
contain
hydrophil
domain
sever
access
continu
immunodomin
epitop
one
aa
expos
polym
unpublish
data
aa
region
clpg
demonstr
accept
variou
small
heterolog
antigen
peptid
without
affect
fibrilla
formatior
featur
make
region
interest
present
foreign
antigen
repeat
unit
along
polym
transmiss
gastroenter
viru
tgev
belong
coronavirida
famili
envelop
positivestrand
rna
virus
caus
gastroenter
result
sever
diarrhea
dehydr
high
mortal
morbid
piglet
week
replic
select
differenti
enterocyt
cover
villi
small
coronavirion
contain
least
four
structur
protein
spike
glycoprotein
tgev
n
nucleoprotein
membran
glycoprotein
sm
protein
tgev
shown
mediat
attach
virion
host
cell
receptor
involv
celltocel
fusion
major
induc
tgev
neutralizingfntibodi
ab
bear
virul
determin
transmiss
gastroenter
diseas
continu
caus
major
econom
loss
swine
industri
date
effect
vaccin
treatment
remain
elus
demand
develop
new
type
vaccin
tgev
describ
exploit
carrierexpress
system
base
fibrilla
e
coli
present
two
antigen
peptid
tgev
immun
system
paper
use
recombin
dna
techniqu
introduc
tandem
site
c
tgevc
aa
tgeva
aa
tgev
aa
part
clpg
tgevc
recogn
mab
elicit
neutral
ab
tgeva
recogn
mab
part
immunogen
conform
antigen
region
contrast
tgevc
highli
conserv
among
enter
respiratori
isol
well
porcin
canin
felin
coronavirus
pregnant
confer
lactogen
protect
addit
region
consist
major
neutral
site
also
interact
tgev
receptor
therefor
hypothes
adequ
present
immun
system
pregnant
sow
one
sever
epitop
region
would
provid
protect
immun
respons
tgev
piglet
epitop
use
vaccin
present
studi
show
mice
immun
purifi
hybrid
fibrilla
develop
system
ab
respons
reactiv
toward
free
synthet
tgev
peptid
nativ
tgev
particl
tgev
infect
indic
c
epitop
immunogen
conform
addit
memori
ab
respons
tgev
epitop
elicit
follow
booster
inocul
tgev
virion
make
fibrillum
good
vector
candid
recombin
vaccin
design
e
coli
strain
use
work
dhsa
brl
life
technolog
inc
bacteria
grown
luriabertani
lb
broth
lb
agar
supplement
tetracyclin
ug
ml
pg
ml
plasmid
figur
ia
fibrillaeencod
clp
gene
cluster
fragment
lowcopi
number
vector
contain
replicon
clp
gene
cluster
contain
seven
structur
gene
encod
secretori
protein
requir
biogenesi
figur
ia
includ
major
clpg
subunit
protein
sever
accessori
protein
involv
stabil
transport
assembl
clpg
clpg
gene
code
clpg
precursor
whose
grocess
result
matur
polypeptid
aa
perform
dna
manipul
czpg
without
affect
rest
operon
clpg
czp
helpergen
clone
two
separ
compat
plasmid
figur
ib
first
contain
clp
ene
cluster
clpg
delet
second
clpg
plasmid
construct
delet
fragment
relig
plasmid
made
clone
czpg
pstihpai
fragment
dowstream
zac
promot
pstismai
site
highcopi
number
vector
l
electl
promega
corpor
carri
colel
replicon
transcomplement
experi
coselect
basi
chloramphenicol
tetracyclin
resist
respect
insert
vector
ppsxlo
figur
construct
two
step
two
consecut
round
oligonucleotidedirect
site
mutagenesi
previous
result
creation
uniqu
spei
bgfli
site
clpg
figur
engin
bgfli
site
allow
subsequ
replac
aa
region
clpg
describ
figur
plasmid
dna
extract
alkalin
lysi
columnpurifi
qiagen
gmbh
germani
dna
fragment
obtain
digest
restrict
endonucleas
purifi
agaros
gel
prepagen
dna
purif
kit
biorad
laboratori
ltd
ligat
standard
techniqu
perform
essenti
describ
buffer
reaction
condit
restrict
enzym
dna
modifi
enzym
use
recommend
supplier
dna
sequenc
perform
denatur
doublestrand
plasmid
dna
dideoxynucleotid
chain
termin
use
intern
primer
datp
label
usb
sequenas
version
dna
sequenc
kit
oligonucleotid
use
studi
synthes
necessari
pagepurifi
eurogentec
belgium
synthet
peptid
obtain
neosystem
strasbourg
franc
puriti
determin
highperform
liquid
chromatographi
prepar
crude
fibrilla
extract
bacteria
grown
overnight
lb
agar
appropri
antibiot
care
scrape
suspend
pb
ph
suspens
vigor
agit
min
top
mix
shaker
place
min
thermoelut
polym
centrifug
min
supernat
contain
free
fibrillar
polym
recov
analysi
purif
nativ
polym
clpg
monom
perform
previous
describ
product
hybrid
polym
detect
situ
coloni
immunoblot
western
immunoblot
follow
page
nativ
denatur
condit
electron
microscopi
coionv
blot
analysi
singl
coloni
streak
solid
agar
lb
plate
contain
appropri
antibiot
overnight
incub
c
nitrocellulos
filter
pore
diamet
pm
schleicher
schuell
care
appli
agar
surfac
blot
block
wash
bsao
tween
pb
bulk
bacteria
remqv
filter
incub
appropri
primari
ab
pbsl
bsa
bound
primari
ab
detect
incub
filter
either
horseradish
peroxidaseconjug
antirabbit
antimous
secondari
ab
develop
h
achloronaphtol
western
blot
analysi
aliquot
either
crude
extract
purifi
polym
purifi
clpg
subunit
mix
equal
volum
x
incomplet
laemmli
buffer
either
boil
min
incub
room
temperatur
obtain
monomer
multimer
form
motein
respect
sampl
page
semidri
cellulos
western
describ
appli
electrotransf
onto
nitroblot
treat
electron
microscopi
analysi
electron
microscopi
purifi
fibrilla
stain
neg
phosphotungst
acid
ionm
colloid
gold
immunolabel
intact
e
coli
cell
carri
essenti
previous
describ
clpg
subunitspecif
rabbit
antiserum
anticlpg
nativ
polymerspecif
rabbit
antiserum
obtain
previous
describ
mab
lafio
direct
tgevc
epitop
tgev
nativ
tgev
coronaviru
describ
delma
et
al
gebauer
et
al
respect
outbr
swiss
inbr
cbaj
hzk
sjl
mice
week
age
use
work
experiment
immun
purchas
iffacredo
le
oncin
franc
detect
ab
direct
clpg
carrier
microtitr
tray
falcon
coat
form
pg
ml
p
urifi
protein
dissoci
mm
carbon
buffer
ph
detect
ab
direct
viral
epitop
highli
activ
microtitr
plate
immulon
ii
dynatech
coat
synthet
peptid
contain
tgevc
sequenc
tvsdssffsygeipf
tgeva
sequenc
smkrsgygqpiag
pg
ml
mm
carbon
buffer
ph
contain
mm
dithiothreitol
incub
h
detect
achiev
incub
abt
nm
h
phosphatecitr
buffer
min
dark
room
temperatur
elisa
assay
perform
duplic
reactiv
titr
antiserum
express
reciproc
highest
dilut
show
twofold
increas
optic
densiti
od
nm
obtain
neg
control
irrelev
peptid
deriv
capsid
protein
footandmouth
diseas
viru
fmdv
capsid
protein
polioviru
use
neg
control
peptidespecif
elisa
antitgev
particl
titr
determin
individu
mous
sera
test
follow
microtitr
plate
coat
overnight
purifi
tgev
pug
ml
pb
wash
tb
buffer
ph
incub
gelatin
mg
ml
tb
h
wash
tbsol
tween
antiserum
dilut
tween
ad
incub
h
wash
tween
bound
ab
detect
incub
alkalin
phosphataselabel
antimous
igg
conjug
tween
h
wash
pnitrophenyl
phosphat
pnpp
mg
ml
diethanolamin
buffer
min
colour
reaction
stope
n
naoh
antiviru
titr
express
reciproc
highest
dilut
give
od
nm
refer
serum
includ
experi
neg
control
sera
mice
hyperimmun
hybrid
fibrilla
carri
rotaviru
mean
background
nonspecif
ab
titr
sera
hyperimmun
mice
tgev
neutral
determin
use
limit
dilut
briefli
serial
twofold
threefold
dilut
antisera
mix
viru
suspens
contain
pfu
tgev
purduel
strain
incub
h
c
x
trypsin
swine
testi
st
cell
eagl
medium
supplement
newborn
calf
serum
ad
neutral
titr
determin
h
later
calcul
mean
highest
dilut
neutral
cytopath
effect
duplic
experi
refer
serum
includ
experi
electron
microscopi
goldimmunolabel
aproduc
e
coli
cell
suggest
capsular
organ
figur
ic
purifi
form
reveal
abund
fine
fibrillar
organel
nm
diamet
figur
zd
western
immunoblot
experi
use
antiserum
nativ
appear
ladder
band
regulari
increas
molecular
mass
correspond
multimer
form
figur
ie
denatur
migrat
singl
band
consist
essenti
major
subunit
monom
autonom
reassoci
vitro
oligomer
reaggreg
complex
figur
ze
tgevc
tgeva
peptid
tandemli
insert
aa
region
major
clpg
subunit
figur
two
step
ppsxlo
express
mutant
protein
figur
first
step
synthet
doublestrand
oligonucleotid
specifi
tgeva
epitop
figur
ligat
speiibgflidigest
ppsxlo
lead
plasmid
express
hybrid
protein
figur
previous
second
step
synthet
doublestrand
oligonucleotid
encod
tgevc
epitop
figur
ligat
speidigest
result
plasmid
express
hybrid
protein
insert
extra
aa
figur
allow
express
hybrid
fibrilla
transfer
e
coli
dhsa
one
transform
screen
situ
colonyimmunoblot
reactiv
toward
tgevc
sitespecif
mab
tgeva
sitespecif
mab
laflo
clpgspecif
antiserum
select
electron
microscopi
analysi
immunogoldlabel
e
coli
cell
bear
confirm
product
hybrid
fibrilla
cell
surfac
figur
hybrid
fibrilla
extract
thermoelut
procedur
describ
separ
l
l
page
denatur
nativ
condit
western
blot
analysi
figur
denatur
form
hybrid
consist
monom
exhibit
two
protein
band
react
anticlpg
antiserum
figur
upper
band
repres
expect
fulllength
hybrid
protein
sinc
immunolog
reveal
addit
laflo
sinc
migrat
slightli
slower
wildtyp
clpg
protein
contrast
lower
band
migrat
faster
clpg
recogn
anticlpg
laflo
abil
hybrid
subunit
polymer
chimerit
fibrillum
structur
evidenc
western
blot
use
page
nondenatur
condit
figur
hybrid
fibrillum
appear
ladder
oligomer
band
regulari
increas
molecular
mass
constitut
polymer
form
chimera
oligom
migrat
doubl
protein
band
major
upper
band
react
laflo
minor
lower
band
altogeth
find
demonstr
normal
antigen
properti
two
viral
epitop
expos
hybrid
fibrilla
e
coli
cellsurfac
howev
result
also
show
full
fusion
construct
partial
cleav
like
undefin
bacteri
proteas
unlik
tgevc
tgeva
truncat
form
hybrid
antigen
inact
test
possibl
immun
respons
tgeva
tgevc
insert
clpg
modul
mous
haplotyp
compar
immunogen
protein
five
strain
inbr
mice
also
outbr
swiss
mice
figur
group
five
anim
belong
six
differ
strain
mice
intraperiton
ip
immun
purifi
monom
case
immun
result
elicit
ab
respons
clpg
tgevc
tgeva
restrict
essenti
haplotyp
moreov
anticlpg
antipeptid
c
titr
posit
correl
figur
mice
haplotyp
clearli
appear
lowest
ab
produc
whatev
antigen
test
product
anticlpg
antipeptid
c
better
cbaj
sjl
swiss
mice
former
latter
appear
best
respond
clpgfuse
peptid
outbr
mice
give
high
immun
respons
chose
carri
immunolog
studi
addit
outbr
statu
seem
satisfi
inbr
mice
artifici
select
immunolog
respons
restrict
laboratori
anim
haplotyp
immunogen
potenti
fusion
construct
evalu
immunogen
potenti
chimerit
construct
compar
anticlpg
antipeptid
antipeptid
c
antitgev
particl
virusneutr
ab
respons
follow
ip
immun
outbr
swiss
mice
either
hybridexpress
bacteria
purifi
hybrid
polym
purifi
monom
figur
found
mice
develop
serum
ab
signific
titr
capabl
recogn
clpg
carrier
protein
free
synthet
tgev
peptid
viru
particl
antiviru
titr
equival
whatev
type
hybridcontain
prepar
use
immun
express
tgev
site
c
fusion
protein
surfac
e
coli
led
induct
tgevneutr
ab
purifi
recombin
antigen
use
immunogen
live
vector
administ
ab
respons
mice
immun
bacteria
lower
mice
immun
purifi
protein
probabl
lower
yield
hybrid
protein
associ
bacteria
compar
pg
inocul
purifi
protein
previous
nevertheless
result
indic
two
tgev
peptid
immunogen
nativ
clpg
fibrillaeassoci
conform
investig
whether
fibrillaeassoci
tgev
epitop
capabl
gener
memori
bcell
swiss
mice
immun
purifi
hybrid
fibrilla
maintain
least
day
booster
either
homolog
hybrid
fibrilla
figur
tgev
virion
figur
six
day
later
expect
strong
memori
ab
respons
induc
two
tgev
peptid
carrier
protein
follow
booster
inocul
homolog
hybrid
fibrilla
figur
interest
memori
ab
respons
viral
peptid
also
induc
follow
booster
inocul
viru
day
last
immun
antipeptid
antipeptid
c
titr
increas
respect
figur
anamnest
effect
specif
site
c
sinc
condit
immun
booster
control
mice
inocul
differ
hybrid
carri
rotaviru
epitop
instead
tgev
epitop
produc
antipeptid
weak
respons
c
peptid
follow
inocul
tgev
figur
antipeptid
c
titr
elicit
control
mice
day
lower
elicit
mice
immun
fibrilla
carri
tgev
epitop
therefor
tgeva
tgevc
fibrillaeassoci
form
fusion
major
clpg
subunit
induc
memori
ab
like
bcell
activ
tgev
epitop
natur
viral
conform
compar
bacteri
protein
use
exposur
vector
heterolog
antigen
determin
see
ref
review
fibrilla
fhnbriae
sever
advantag
favour
use
vaccin
extracellular
appendag
product
purif
quick
easi
econom
mean
obtain
vaccin
compon
reproduct
high
polymer
allow
foreign
antigen
previous
insert
major
fibrillar
subunit
expos
repeatedli
along
fibrillum
length
present
great
quantiti
entir
bacteri
cell
surfac
may
enhanc
good
immunogen
exhibit
lowlevel
toxic
sinc
capabl
bind
speoific
receptor
mucos
surfac
may
great
valu
targetin
f
immunogen
mani
use
carrier
system
obtain
recombin
polym
protein
describ
studi
antigen
induc
serolog
respons
till
immunolog
memori
effect
immun
purifi
hybrid
fimbria
describ
present
work
undertaken
test
whether
effect
vaccin
tgev
could
envisag
base
exploit
e
coli
fibrilla
deliveri
system
purpos
two
antigen
peptid
protein
tgev
name
tgevc
aa
tgeva
aa
tandemli
insert
aa
part
major
fibrillar
clpg
subunit
shown
previous
introduct
differ
foreign
epitop
clpg
region
result
effect
assembl
hybrid
subunit
fibrillaej
suggest
aa
region
would
favour
region
insert
result
report
provid
evid
carrierdeliveri
system
offer
realist
epitopebas
strategi
recombin
tgev
vaccin
develop
sinc
insert
tgeva
plu
tgevc
consist
extra
aa
interfer
fibrilla
format
two
viral
epitop
expos
immunogen
conform
clpg
subunit
fibrilla
e
coli
context
clpg
carrier
highli
immunogen
hybrid
fibrilla
elicit
system
ab
respons
reactiv
tgev
peptid
nativ
viru
particl
viru
infect
tgev
peptid
fuse
fibrilla
induc
ab
memori
bcell
activ
tgev
epitop
natur
viral
conform
outbr
mous
popul
unclear
whether
memori
respons
result
cooper
effect
tgeva
tgevc
peptid
one
act
helper
epitop
b
determin
b
memori
immunogen
recombin
bacteria
purifi
hybrid
clpg
monom
chimer
polym
studi
ip
immun
mice
sinc
mucos
immun
essenti
provid
protect
tgev
infect
evalu
also
secretori
immunorespons
variou
live
e
coli
produc
differ
fibrilla
chimera
tgeva
orand
tgevc
epitop
insert
differ
permiss
site
clpg
current
data
support
iga
respons
thu
although
result
bacteria
express
tgevc
tgeva
fusion
peptid
region
clpg
work
focus
avail
yet
data
bacteria
present
tgevc
epitop
region
indic
recombin
bacteria
capabl
elicit
iga
respons
mice
case
five
outbr
swiss
mice
inocul
oral
x
live
bacteria
day
specif
iga
ab
fibrillum
carrier
tgevc
peptid
detect
day
later
intestin
fluid
mean
titr
respect
therefor
think
fibrilla
chimera
may
prove
effici
compon
combin
mucos
adjuv
live
oral
vaccin
especi
sinc
chimer
fibrilla
induc
immunolog
memori
mucos
immun
outbr
anim
sinc
also
express
attenu
salmonella
typhimurium
strain
